- Advertisement -
Home Uncategorized TRUMP calls for strengthening domestic supply chain for essential medicines; Indian pharma...

TRUMP calls for strengthening domestic supply chain for essential medicines; Indian pharma companies’ worries increase

0

India exports 6 billion dollar medicines to America. Representatives of the Indian pharma industry say that at present, this order of Trump will not have much effect.


The concern of Indian pharma companies has increased after President Donald Trump’s order to increase production of essential medicines in America. However, they will not be affected immediately. But later on they may face problems. The largest supplier companies of US drug market are Indians. Indian pharmaceutical companies have a large participation in the US pharmaceutical market, so domestic pharma companies are worried.

Indian companies are currently unaffected


Representatives of domestic pharmaceutical companies say that currently there will not be a big impact, but if the purchase of local medicines is made mandatory in the US Centers for Medicare and Medicaid Services, then Indian pharma companies may be affected. In its order dated August 6, Trump had asked the agencies involved in drug procurement to find out the weaknesses in the supply chain of essential medicines. US Food and Drug Administration Commissioner Stephen Han has been asked to prepare a draft in three so that the necessary medicines are available in sufficient quantities.

Also Read: Under this scheme of Modi government, a bank account is opened for free, this service is available with insurance of 2 lakhs.


More impact on China than India

This trump order may affect China more than India, from where bulk drugs are exported worldwide. India too had to face the problems of the supply chain of bulk drugs recently. Production was halted in China’s Huawei province due to the lockdown. Due to this, the supply of bulk drugs in India was affected and the shortage of medicines started. India exports 6 billion dollar medicines to America. Representatives of the Indian pharma industry say that at present, this order of Trump will not have much effect. But it has to be seen further whether the US pharmaceutical companies will be able to make the necessary medicines at a lower price. Since the cost of making medicines in America is high, the supply of generic medicines from India is quite high there

- Advertisement -DISCLAIMER
We have taken all measures to ensure that the information provided in this article and on our social media platform is credible, verified and sourced from other Big media Houses. For any feedback or complaint, reach out to us at businessleaguein@gmail.com

Exit mobile version